A nurse is assisting with the care of a client who is in labor.
The client's labor is difficult and prolonged and she reports a severe backache.
Which of the following factors is a contributing cause of difficult, prolonged labor?

Choice A rationale:

There is no evidence to suggest that epidural anesthesia delays the rupture of fetal membranes. The timing of rupture of fetal

membranes is influenced by various factors, including the strength of uterine contractions, the position of the baby, and the

elasticity of the amniotic sac. Epidural anesthesia does not directly affect these factors.

Choice B rationale:

Epidural anesthesia can prolong labor by interfering with the natural process of labor. It can weaken uterine contractions,

slow down cervical dilation, and potentially lead to a prolonged second stage of labor. This is because the anesthesia blocks the

nerve signals that control the muscles of the uterus. When these signals are blocked, the contractions may become less

frequent and less intense. This can delay the progress of labor and increase the risk of interventions such as forceps delivery

or cesarean section.

Choice C rationale:

While epidural anesthesia can have some effects on the baby, it is not a primary cause of fetal depression. Fetal depression is

typically caused by other factors, such as decreased oxygen supply to the baby, maternal infection, or placental problems.

Epidural anesthesia can sometimes lead to a temporary decrease in the baby's heart rate, but this is usually well-managed by

the healthcare team and does not typically lead to significant fetal depression.

Choice D rationale:

Epidural anesthesia does not typically cause maternal hypertension. In fact, it can sometimes have the opposite effect and

cause a slight decrease in blood pressure. This is because the anesthesia can relax the blood vessels, which can lead to a drop

in blood pressure. However, this is usually not a significant concern and is easily managed by the healthcare team.

Choice A rationale:

Rh positive individuals already have the Rh factor on their red blood cells, so they do not need Rho(D) immune globulin to

prevent sensitization.

The newborn being Rh positive does not pose a risk to an Rh positive mother, as their blood types are compatible.

Choice B rationale:

Rh positive individuals cannot develop antibodies against the Rh factor, as it is already present on their own red blood cells.

The newborn's Rh negative status does not create a risk of sensitization for the mother, as there is no Rh factor to trigger an

immune response.

Choice C rationale:

If both the mother and the newborn are Rh negative, there is no risk of Rh incompatibility.

This is because neither individual has the Rh factor on their red blood cells, so there is no potential for sensitization.

Choice D rationale:

When an Rh negative mother carries an Rh positive fetus, there is a risk of Rh sensitization during pregnancy and delivery.

This occurs when fetal blood cells cross the placenta and enter the mother's bloodstream, exposing her immune system to the

Rh factor.

If the mother's immune system recognizes the Rh factor as foreign, it can produce antibodies against it.

These antibodies can cross the placenta in subsequent pregnancies and attack the red blood cells of Rh positive fetuses,

leading to hemolytic disease of the newborn (HDN).

Rho(D) immune globulin is a medication that can prevent Rh sensitization by binding to Rh positive fetal blood cells that have

entered the mother's bloodstream.

This prevents the mother's immune system from recognizing the Rh factor and producing antibodies.

Rho(D) immune globulin is typically given to Rh negative mothers within 72 hours of delivery of an Rh positive newborn, as well as after other events that could lead to Rh sensitization, such as miscarriage, abortion, or ectopic pregnancy.